Better Business Bureau, National Advertising Division Will Refer Willow Health to State and Federal Regulatory Authorities for its Compounded Semaglutide Product Claims, (December 4, 2025) [2] See e.g
Sitagliptin reduces albuminuria in patients with type 2 diabetes
Studies in rats and mice showed an increase in the occurrence of benign C-cell adenomas at liraglutide doses that are similar to those seen in humans at the approved doses
For many patients, these effects tend to diminish over time with continued treatment
Work with the FDA and other agencies to update guidelines for lifestyle interventions in pediatric clinical trials that incorporate state-of-the-art approaches to quantifying, monitoring, and evaluating physical activity, adherence to diet, and accurate measurement of body composition beyond the current reliance on the body mass index (BMI), a suboptimal metric of overweight and obesity in adolescents
Dietrich Bsselberg, January 2023-Current) from the Qatar National Research Fund (QNRF, a member of Qatar Foundation)